Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Protein Engineering Market Size Forecast: How Big Could The Market Get By 2030?
The protein engineering market has experienced swift expansion in recent years. Its valuation is projected to increase from $4.62 billion in 2025 to $5.31 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.8%. The historical growth can be attributed to factors such as the expansion of biopharmaceutical research activities, the increasing availability of advanced laboratory instruments, a rise in academic protein research, escalating investments in biotechnology, and improvements in protein characterization methods.
The protein engineering market is projected to witness substantial expansion in the upcoming years. Its valuation is expected to reach $9.3 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.1%. This projected growth stems from factors such as an escalating demand for next-generation biologics, the development of personalized medicine, the increasing utilization of engineered proteins in vaccines, a growing embrace of computational biology, and augmented collaboration between industry and academia. Significant trends anticipated during this period include the wider adoption of rational protein design methodologies, an increased application of AI in protein modeling, a burgeoning demand for engineered therapeutic proteins, the expansion of bespoke protein engineering services, and a more sophisticated integration of bioinformatics tools.
Get A Free Sample Report With In-Depth Market Insights:
Protein Engineering Market Growth Factors Behind Sustained Expansion
The growing need for protein-based drugs is driving the protein engineering market. Protein-based drugs are substances that incorporate proteins for their therapeutic actions. These therapeutic proteins, or protein-based drugs, are essentially medicines that are genetically modified versions of human proteins found naturally. Protein engineering involves modifying protein sequences by substituting, inserting, or deleting nucleotides within the gene that encodes them, aiming to create protein-based drugs better suited for specific applications. For instance, according to a study by Lancet Diabetes and Endocrinology journal, nearly 80 million people with type-2 diabetes will require insulin by 2030, marking a rise of 20%. Thus, the increasing demand for protein-based drugs is fueling the protein engineering market.
Protein Engineering Market Segment Performance And Emerging Opportunities
The protein engineering market covered in this report is segmented –
1) By Product And Services: Instruments, Reagents, Services And Software
2) By Technology: Irrational Protein Design, Rational Protein Design
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations
Subsegments:
1) By Instruments: Protein Purification Systems, Spectroscopy And Imaging Systems, Mass Spectrometers
2) By Reagents: Enzymes, Antibodies, Labeling And Detection Reagents
3) By Services And Software: Custom Protein Engineering Services, Analytical Services, Consulting Services, Modeling And Simulation Software, Data Analysis Software, Bioinformatics Tools
Protein Engineering Market Growth Trends Reshaping The Competitive Landscape
Leading companies within the protein engineering market are creating novel products utilizing cutting-edge technologies, including the SUREtechnology platform, to improve the stability, effectiveness, and production capabilities of therapeutic proteins. This SUREtechnology platform facilitates accurate modifications, supporting the creation of advanced biologics that offer enhanced therapeutic attributes, fewer adverse effects, and greater efficiency in production. As an illustration, KBI Biopharma, a US-based biotechnology firm, introduced SUREmAb in September 2023, representing an innovative solution developed on its SUREtechnology platform. This product is designed for the optimized, secure, and economically efficient development and manufacturing of monoclonal antibodies (mAbs), addressing the increasing need for biopharmaceuticals. SUREmAb facilitates swift advancement from transfection to Research Cell Bank (RCB) in as little as 9 weeks, along with enabling drug substance release within 11 months.
Protein Engineering Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the protein engineering market are Codexis Inc., GenScript Biotech Corporation, Abzena plc, Aragen Bioscience Inc., Enantis s.r.o., Creative BioMart, Twist Bioscience Corporation, Ginkgo Bioworks Inc., Amyris Inc., Absci Corporation, Generate Biomedicines Inc., ProteinQure Inc., Zymeworks Inc., Adimab LLC, Ichnos Sciences SA, Synthego Corporation, Evotec SE, Pieris Pharmaceuticals Inc., MacroGenics Inc., Adagene Inc.
View The Full Protein Engineering Market Report:
Protein Engineering Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the protein engineering market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
